<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-25705" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part indexed="no" book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Nephrolithiasis (Kidney Stones) (Archived)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nojaba</surname>
            <given-names>Leila</given-names>
          </name>
          <aff>Orange Park Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Guzman</surname>
            <given-names>Nilmarie</given-names>
          </name>
          <aff>Orange Park Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leila Nojaba declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nilmarie Guzman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-25705.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Nephrolithiasis, or kidney stones, is&#x000a0;the most common condition affecting the urinary system, affecting about 12% of the world population, with a yearly incidence of 600,000&#x000a0;in America.&#x000a0;It is the result of a crystal or crystalline concretion&#x000a0;traveling from the kidney through the genitourinary system.<xref ref-type="bibr" rid="article-25705.r1">[1]</xref><xref ref-type="bibr" rid="article-25705.r2">[2]</xref>&#x000a0;Kidney stones correlate with an increased risk of chronic kidney diseases, end-stage renal failure, cardiovascular diseases, diabetes, and hypertension.<xref ref-type="bibr" rid="article-25705.r3">[3]</xref></p>
      </sec>
      <sec id="article-25705.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Most&#x000a0;patients with nephrolithiasis form calcium stones (80%), most of which are composed primarily of calcium oxalate or calcium phosphate. The other main types include uric acid, struvite (magnesium ammonium phosphate), and cystine stones. Of note, one patient may have a stone that contains more than one type of crystal.</p>
        <p><bold>Risk Factors -&#x000a0;</bold>Influenced by certain diseases, habits, composition of urine.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Personal history of prior kidney stones increases the risk of kidney stones&#x000a0;<xref ref-type="bibr" rid="article-25705.r4">[4]</xref>&#x000a0;by 15% within the first year, and 50% within the next ten years.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>A family history of kidney stones increases the risk by 2.5 times.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Increased enteric oxalate absorption, typically due to malabsorption, leads to increased formation of calcium oxalate crystals. &#x000a0;</p>
          </list-item>
          <list-item>
            <p>Urinary tract infections altering urinary pH in the setting of urease-producing bacteria, producing struvite crystals</p>
          </list-item>
          <list-item>
            <p>Low fluid intake&#x000a0;<xref ref-type="bibr" rid="article-25705.r5">[5]</xref></p>
          </list-item>
          <list-item>
            <p>History of&#x000a0;diabetes, obesity, gout, and hypertension&#x000a0;<xref ref-type="bibr" rid="article-25705.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Acidic urine (pH&#x0003c; 5.5), which promotes uric acid formation in the setting of chronic diarrhea and gout</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25705.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence and recurrence rates of nephrolithiasis are increasing, with limited options of effective drugs and procedures, affecting about 12% of the population worldwide. The incidence is estimated at 600,000 in the U.S. Between the ages of 20&#x000a0;to 49; kidney stones affect men more frequently than in women (2&#x000a0;to 1). The lifetime recurrence rate is higher in males than in females. This fact is attributed to the increasing incidence of obesity due to poor dietary habits and lack of physical activity.</p>
      </sec>
      <sec id="article-25705.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Renal stone formation involves physicochemical changes and urine supersaturation. In the setting of&#x000a0;supersaturation, solutes precipitate in the urine leading to nucleation and crystal concretions. PH and specific concentrations of excess substances influence the transformation of a liquid to a solid. In respect to nephrolithiasis, supersaturation of stone-forming constituents like calcium, phosphorus, uric acid, oxalate, cystine, and low urine volume are risk factors for crystallization.<xref ref-type="bibr" rid="article-25705.r7">[7]</xref>&#x000a0;Nephrolithiasis is preventable by avoiding supersaturation.</p>
      </sec>
      <sec id="article-25705.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Urine microscopy is useful in analyzing the kidney stone if they are obtainable via urine straining. Below are the crystal formations typically associated with each stone type&#x000a0;<xref ref-type="bibr" rid="article-25705.r8">[8]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Calcium oxalate: envelope or dumbbell-shaped
<list list-type="bullet"><list-item><p>Calcium oxalate is the primary component of the majority of stones. They typically occur in the setting of&#x000a0;hypercalciuria, hyperoxaluria, hypomagnesuria, hypercystinuria,&#x000a0;hypocitraturia.&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Calcium phosphate: amorphous, wedge-shaped prisms in rosettes&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Magnesium ammonium phosphate: coffin lid shaped&#x000a0;
<list list-type="bullet"><list-item><p>Also known as struvite stones, seen in infectious stones. In the setting of infections with bacteria that produce urease, such as Proteus mirabilis, Klebsiella pneumonia, Enterobacter, and Pseudomonas aeruginosa. The urease produces ammonia and CO2, which creates basic pH urine (&#x0003e;7)<italic toggle="yes">. &#x000a0;&#x000a0;</italic>&#x000a0;&#x000a0;</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Uric acid: rhomboid shaped&#x000a0;
<list list-type="bullet"><list-item><p>These stones are typically idiopathic. They occur in patients whose diets are high in protein, which acidifies&#x000a0;urines pH (&#x0003c;7), allowing for uric acid stone formation.</p></list-item></list>
</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cystine: hexagon-shaped
<list list-type="bullet"><list-item><p>These stones are caused by a genetic defect in the&#x000a0;transport of&#x000a0;the amino acid cystine, resulting in&#x000a0;hypercystinuria.</p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25705.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with nephrolithiasis, when limited to the kidney, will be asymptomatic. The common symptoms associated with kidney stones, including acute pain radiating to the groin, occurs once the stone begins descending the ureters from the kidneys.&#x000a0;It is often described as dull, colicky, sharp, and severe pain. &#x000a0;The pain is often associated with nausea and vomiting due to the severity of pain. These symptoms are attributed to the&#x000a0;peristalsis of the genitourinary tract smooth muscle against the stone. Hematuria is commonly reported as well, due to the injury against the genitourinary tract secondary to the stone; this is confirmable via urinalysis.&#x000a0;</p>
        <p>If the stone becomes infected, patients may develop&#x000a0;fever, chills, or other signs of worsening systemic signs of infection (i.e., shock). The physical exam may reveal costovertebral tenderness.&#x000a0;&#x000a0;Obstruction can occur, and pyelonephritis with concurrent hydronephrosis can result. This&#x000a0;situation can be&#x000a0;severe and life-threatening, requiring emergency decompression surgery.</p>
      </sec>
      <sec id="article-25705.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Laboratory tests to assess renal function, including either a basic or comprehensive metabolic panel, may be used. Additionally, a urinalysis, urine electrolytes, and urine pH can help direct towards a specific type of stone.&#x000a0;</p>
        <p>A KUB (kidney-ureter-bladder) X-ray is also an option; however, uric acid stones are difficult to assess with this imaging. A CT of the abdomen and pelvis without contrast can also be performed and has higher sensitivity. Contrast medium is typically avoided when there is a concern for a kidney stone as enhancement of the vessels and ureters can obscure stone findings.&#x000a0;</p>
      </sec>
      <sec id="article-25705.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Kidney stones are extremely painful. Pain control is of utmost importance&#x000a0;with&#x000a0;NSAIDs by decreasing smooth muscle stimulation and ureteral spasm. Additionally, it is essential to increase fluid intake.&#x000a0;Tamsulosin, may also&#x000a0;aid stone passage, and also reduces smooth muscle stimulation. It is typically useful in those in the distal ureter and sizes between 5 to 10 mm. &#x000a0;</p>
        <p>Stones greater than 6mm are likely to require some intervention, including percutaneous nephrolithotomy, rigid and flexible ureteroscopy, and shock wave lithotripsy.<xref ref-type="bibr" rid="article-25705.r9">[9]</xref></p>
      </sec>
      <sec id="article-25705.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Conditions listed below may mimic nephrolithiasis-induced flank pain:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pyelonephritis, which typically presents with pyuria, fevers, chills and flank pain</p>
          </list-item>
          <list-item>
            <p>Ovarian cyst torsion</p>
          </list-item>
          <list-item>
            <p>Ectopic pregnancies&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Intestinal associated diseases, including obstruction, appendicitis, and diverticulitis</p>
          </list-item>
          <list-item>
            <p>Cholecystitis, hepatitis, and biliary colic&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Herpes zoster&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Narcotic-seeking individuals&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Renal cell carcinomas</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25705.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Kidney stones that do not pass can become obstructive and can subsequently cause acute renal failure, or it can also become a nidus for infection, which can eventually be lethal. If the patient undergoes nephrostomy tube placement, then there is a chance of bleeding, renal collecting system injury, injury of visceral organs, pulmonary complications, thromboembolic complications, and extrarenal stone migration.<xref ref-type="bibr" rid="article-25705.r10">[10]</xref></p>
      </sec>
      <sec id="article-25705.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Several complications can arise due to kidney stones, and subsequently, stones that&#x000a0;cause obstruction. These include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Abscess formation</p>
          </list-item>
          <list-item>
            <p>Urosepsis</p>
          </list-item>
          <list-item>
            <p>Urinary fistula formation</p>
          </list-item>
          <list-item>
            <p>Ureteral scarring and stenosis</p>
          </list-item>
          <list-item>
            <p>Ureteral perforation</p>
          </list-item>
          <list-item>
            <p>Renal function loss due to long-standing obstruction</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25705.s12" sec-type="Consultations">
        <title>Consultations</title>
        <p>Failure of stone passage within&#x000a0;a month warrants a urology consultation.</p>
        <p>Indications for hospitalization and urgent urology consultation and intervention are:</p>
        <list list-type="order">
          <list-item>
            <p>An obstructed and infected upper urinary system</p>
          </list-item>
          <list-item>
            <p>Intractable vomiting or pain</p>
          </list-item>
          <list-item>
            <p>Anuria or deteriorating renal function</p>
          </list-item>
          <list-item>
            <p>History of transplanted kidney or solitary kidney with obstructing stone&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-25705.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>
<bold>Identification and Subsequent Prevention</bold>
</p>
        <p>Effective kidney stone prevention depends on stone identification. Implementing&#x000a0;preventive strategies that include primarily dietary changes and/or pharmacological treatments may be required. Additionally, regardless of underlying etiology, increasing water intake to maintain two liters of urine output per day,&#x000a0;a low salt diet, and a decreased amount of animal protein consumption should be a daily practice. For absorptive hyperoxaluria, a low oxalate diet and increased dietary calcium intake are both recommended.&#x000a0;Calcium supplements can&#x000a0;reduce oxalate absorption, and can be protective.&#x000a0;For struvite stones,&#x000a0;patients must receive careful follow-up until the infection has resolved.<xref ref-type="bibr" rid="article-25705.r11">[11]</xref></p>
      </sec>
      <sec id="article-25705.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Nephrolithiasis&#x000a0;frequently poses a prevention and treatment dilemma. These patients may exhibit non-specific signs and symptoms such as abdominal pain, nausea, and urinating difficulties. Knowledge of the stone type can point the patient to changes in lifestyle habits that would prevent further stone formations. Patient adherence, along with detailed lifestyle changes, should be discussed between the patients, primary physician, and the urologist. Recurrent stone formation can exacerbate worsening renal function, especially in those with a history of end-stage renal disease. If given medication as treatment or prevention, it is also just as necessary for the pharmacist to recognize the use of the medication and further counsel patients on lifestyle habit changes.&#x000a0;</p>
      </sec>
      <sec id="article-25705.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=25705&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=25705">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/25705/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=25705">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-25705.s16">
        <fig id="article-25705.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Nephrolithiasis, Ultrasound. The image shows a normal kidney with grades of hydronephrosis, twinkle artifact, and ureterovesical junction stone. Contributed by MK Herbst, MD</p>
          </caption>
          <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="collage__hydro__and__uvj__stone_crop.mp4" mime-subtype="mp4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-25705.s17">
        <title>References</title>
        <ref id="article-25705.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alelign</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Petros</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Kidney Stone Disease: An Update on Current Concepts.</article-title>
            <source>Adv Urol</source>
            <year>2018</year>
            <volume>2018</volume>
            <fpage>3068365</fpage>
            <pub-id pub-id-type="pmid">29515627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f3;pez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hoppe</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>History, epidemiology and regional diversities of urolithiasis.</article-title>
            <source>Pediatr Nephrol</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-59</page-range>
            <pub-id pub-id-type="pmid">21476230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sigurjonsdottir</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Runolfsdottir</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Indridason</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Palsson</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Edvardsson</surname>
                <given-names>VO</given-names>
              </name>
            </person-group>
            <article-title>Impact of nephrolithiasis on kidney function.</article-title>
            <source>BMC Nephrol</source>
            <year>2015</year>
            <month>Aug</month>
            <day>28</day>
            <volume>16</volume>
            <fpage>149</fpage>
            <pub-id pub-id-type="pmid">26316205</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kocvara</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Plasgura</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Petr&#x000ed;k</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Louzensk&#x000fd;</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barton&#x000ed;ckov&#x000e1;</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dvor&#x000e1;cek</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>A prospective study of nonmedical prophylaxis after a first kidney stone.</article-title>
            <source>BJU Int</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>84</volume>
            <issue>4</issue>
            <fpage>393</fpage>
            <page-range>393-8</page-range>
            <pub-id pub-id-type="pmid">10468751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lotan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Antonelli</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jim&#x000e9;nez</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Gharbi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Herring</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Beaver</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dennis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Von Merveldt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Carter</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moe</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Pearle</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>The kidney stone and increased water intake trial in steel workers: results from a pilot study.</article-title>
            <source>Urolithiasis</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>45</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-183</page-range>
            <pub-id pub-id-type="pmid">27228999</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abate</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chandalia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cabo-Chan</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Moe</surname>
                <given-names>OW</given-names>
              </name>
              <name>
                <surname>Sakhaee</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance.</article-title>
            <source>Kidney Int</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>386</fpage>
            <page-range>386-92</page-range>
            <pub-id pub-id-type="pmid">14717908</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aggarwal</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Narula</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kakkar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tandon</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators.</article-title>
            <source>Biomed Res Int</source>
            <year>2013</year>
            <volume>2013</volume>
            <fpage>292953</fpage>
            <pub-id pub-id-type="pmid">24151593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coe</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Evan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Worcester</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Kidney stone disease.</article-title>
            <source>J Clin Invest</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>115</volume>
            <issue>10</issue>
            <fpage>2598</fpage>
            <page-range>2598-608</page-range>
            <pub-id pub-id-type="pmid">16200192</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gnyawali</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Pradhan</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Sigdel</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Parajuli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chudal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Poudyal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chapagain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Luitel</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Chalise</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Gyawali</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Efficacy of Tamsulosin plus Tadalafil versus Tamsulosin as Medical Expulsive Therapy for Lower Ureteric Stones: A Randomized Controlled Trial.</article-title>
            <source>Adv Urol</source>
            <year>2020</year>
            <volume>2020</volume>
            <fpage>4347598</fpage>
            <pub-id pub-id-type="pmid">32411212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Expert Panel on Interventional Radiology</collab>
              <name>
                <surname>Scheidt</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Hohenwalter</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Pinchot</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bjurlin</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Braun</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Knavel Koepsel</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Schramm</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sella</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Weiss</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Lorenz</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>ACR Appropriateness Criteria&#x000ae; Radiologic Management of Urinary Tract Obstruction.</article-title>
            <source>J Am Coll Radiol</source>
            <year>2020</year>
            <month>May</month>
            <volume>17</volume>
            <issue>5S</issue>
            <fpage>S281</fpage>
            <page-range>S281-S292</page-range>
            <pub-id pub-id-type="pmid">32370972</pub-id>
          </element-citation>
        </ref>
        <ref id="article-25705.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Skolarikos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Straub</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knoll</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sarica</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pet&#x00159;&#x000ed;k</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>T&#x000fc;rk</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Metabolic evaluation and recurrence prevention for urinary stone patients: EAU guidelines.</article-title>
            <source>Eur Urol</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>750</fpage>
            <page-range>750-63</page-range>
            <pub-id pub-id-type="pmid">25454613</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
